These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 8307249)

  • 1. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
    Maxfield EK; Cameron NE; Cotter MA; Dines KC
    Diabetologia; 1993 Dec; 36(12):1230-7. PubMed ID: 8307249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK
    Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.
    Dines KC; Cotter MA; Cameron NE
    Diabetologia; 1993 Nov; 36(11):1132-8. PubMed ID: 8270127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK
    Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
    Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
    Cameron NE; Cotter MA; Dines KC; Robertson S; Cox D
    Br J Pharmacol; 1993 Aug; 109(4):972-9. PubMed ID: 8401950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
    Cotter MA; Dines KC; Cameron NE
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):534-40. PubMed ID: 7686634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
    Cameron NE; Dines KC; Cotter MA
    Diabetologia; 1994 Dec; 37(12):1209-15. PubMed ID: 7895950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats.
    Robertson S; Cameron NE; Cotter MA
    Diabetologia; 1992 Dec; 35(12):1113-7. PubMed ID: 1478362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist.
    Maxfield EK; Love A; Cotter MA; Cameron NE
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E530-7. PubMed ID: 7573431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE; Cotter MA
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state.
    van Dam PS; van Asbeck BS; Van Oirschot JF; Biessels GJ; Hamers FP; Marx JJ
    Eur J Clin Invest; 2001 May; 31(5):417-24. PubMed ID: 11380593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats.
    Jack AM; Cameron NE; Cotter MA
    J Diabetes Complications; 1999; 13(1):2-9. PubMed ID: 10232703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Maxfield EK
    Diabetologia; 1993 Apr; 36(4):299-304. PubMed ID: 8477873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Robertson S
    Diabetologia; 1992 Jan; 35(1):12-8. PubMed ID: 1371757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima W
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.